The Journal of Urology
Volume 172, Issue 5, Supplement , Pages S23-S27 , November 2004

EXPRESSION OF GENES AND PROTEINS SPECIFIC FOR PROSTATE CANCER

  • EDWARD P. GELMANN

      Affiliations

    • Corresponding Author InformationCorrespondence and requests for reprints: Department of Oncology, Lombardi Cancer Center, Georgetown University, 3800 Reservoir Rd., Northwest, Washington, D. C. 20057 (telephone: 202-444-2207; FAX: 202-444-1229)
    • ,
  • O. JOHN SEMMES

REFERENCES 

  1. Asmann YW , Kosari F , Wang K , Cheville JC , Vasmatzis G . Identification of differentially expressed genes in normal and malignant prostate by electronic profiling of expressed sequence tags . Cancer Res . 2002;62:3308
  2. Waghray A , Schober M , Feroze F , Yao F , Virgin J , Chen YQ . Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer . Cancer Res . 2001;61:4283
  3. Xu J , Stolk JA , Zhang X , Silva SJ , Houghton RL , Matsumura M , et al.   Identification of differentially expressed genes in human prostate cancer using subtraction and microarray . Cancer Res . 2000;60:1677
  4. Jiang Z , Woda BA , Yang XJ . Alpha-methylacyl coenzyme A racemase as a marker for prostate cancer . JAMA . 2002;287:3080
  5. Magi-Galluzzi C , Luo J , Isaacs WB , Hicks JL , de Marzo AM , Epstein JI . Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy . Am J Surg Pathol . 2003;27:1128
  6. Luo J , Duggan DJ , Chen Y , Sauvageot J , Ewing CM , Bittner ML , et al.   Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling . Cancer Res . 2001;61:4683
  7. Welsh JB , Sapinoso LM , Su AI , Kern SG , Wang-Rodriguez J , Moskaluk CA , et al.   Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer . Cancer Res . 2001;61:5974
  8. Dhanasekaran SM , Barrette TR , Ghosh D , Shah R , Varambally S , Kurachi K , et al.   Delineation of prognostic biomarkers in prostate cancer . Nature . 2001;412:822
  9. Magee JA , Araki T , Patil S , Ehrig T , True L , Humphrey PA , et al.   Expression profiling reveals hepsin overexpression in prostate cancer . Cancer Res . 2001;61:5692
  10. Rhodes DR , Barrette TR , Rubin MA , Ghosh D , Chinnaiyan AM . Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer . Cancer Res . 2002;62:4427
  11. Cheng WS , Giandomenico V , Pastan I , Essand M . Characterization of the androgen-regulated prostate-specific T cell receptor gamma-chain alternate reading frame protein (TARP) promoter . Endocrinology . 2003;144:3433
  12. Wolfgang CD , Essand M , Lee B , Pastan I . T-cell receptor gamma chain alternate reading frame protein (TARP) expression in prostate cancer cells leads to an increased growth rate and induction of caveolins and amphiregulin . Cancer Res . 2001;61:8122
  13. Saverio B , Pierpaola D , Serenella A , Cesare C , Bruno M , Auro T , et al.   Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens . Cancer Res . 2000;60:28
  14. Adam BL , Qu Y , Davis JW , Ward MD , Clements MA , Cazares LH , et al.   Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men . Cancer Res . 2002;62:3609
  15. Petricoin EF , Ornstein DK , Paweletz CP , Ardekani A , Hackett PS , Hitt BA , et al.   Serum proteomic patterns for detection of prostate cancer . J Natl Cancer Inst . 2002;94:1576
  16. Srivastava S , Rossi SC . Early detection research program at the NCI . Int J Cancer . 1996;69:35
  17. Gohagan JK , Levin D , Prorok PC , Sullivan D . The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial . Control Clin Trials . 2001;21(suppl):249S
  18. Zhou M , Jiang Z , Epstein JI . Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer . Am J Surg Pathol . 2003;27:772
  19. Mousses S , Bubendorf L , Wagner U , Hostetter G , Kononen J , Cornelison R , et al.   Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays . Cancer Res . 2002;62:1256
  20. Gupta S , Ahmad N , Marengo SR , MacLennan GT , Greenberg NM , Mukhtar H . Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice . Cancer Res . 2000;60:5125
  21. Simoneau AR , Gerner EW , Phung M , McLaren CE , Meyskens FL . Alpha-difluoromethylornithine and polyamine levels in the human prostate: results of a phase IIa trial . J Natl Cancer Inst . 2001;93:57
  22. Messing EM , Love RR , Tutsch KD , Verma AK , Douglas J , Pomplun M , et al.   Low-dose difluoromethylornithine and polyamine levels in human prostate tissue . J Natl Cancer Inst . 1999;91:1416

 Supported by National Institutes of Health Grants ES09888 and CA96854 (EPG) and CA85067-05 (OJS).

PII: S0022-5347(05)61303-1

doi: 10.1097/01.ju.0000141781.70474.48

The Journal of Urology
Volume 172, Issue 5, Supplement , Pages S23-S27 , November 2004

Article Tools

* Image Usage & Resolution